6-May-2026 RAS inhibitor daraxonrasib demonstrates initial anti-tumor activity in pancreatic cancer University of Texas M. D. Anderson Cancer Center Peer-Reviewed Publication
6-May-2026 RAS(ON) inhibitor daraxonrasib shows promising results in advanced pancreatic cancer phase 1/2 study Dana-Farber Cancer Institute Peer-Reviewed Publication
6-May-2026 Mount Sinai study identifies new strategy to overcome immunotherapy resistance in colorectal cancer The Mount Sinai Hospital / Mount Sinai School of Medicine Peer-Reviewed Publication
6-May-2026 ASCO 2026 Tip Sheet - Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Reports and Proceedings
6-May-2026 Mayo Clinic and Stanford researchers develop first blood test to map tumor “neighborhoods,” improving prediction of therapy response Mayo Clinic Peer-Reviewed Publication
6-May-2026 ERASur colorectal cancer trial reaches one-third patient accrual milestone Alliance for Clinical Trials in Oncology Business Announcement
6-May-2026 Johns Hopkins physicians achieve 95% cure rate for sickle cell disease with bone marrow transplant Johns Hopkins Medicine Peer-Reviewed Publication
6-May-2026 Researchers show CRISPR can selectively destroy cells, a cancer-treatment goal Utah State University Peer-Reviewed Publication
6-May-2026 Trinity researchers publish ‘playbook’ for understanding pancreatic cancer, one of the deadliest cancers Trinity College Dublin Peer-Reviewed Publication
6-May-2026 Thousands of new proteins revealed in dark proteome Princess Máxima Center for Pediatric Oncology Peer-Reviewed Publication